SCHEMBL238685

SCHEMBL238685

O=P(c1ccccc1)(c1ccccc1)c1cccc2ccc(-c3ccccc3)nc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.51
TOP1 P11387 1/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
RAB9A P51151 2/20 0.42
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ASIC3 Q9UHC3 1/20 0.37
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 1/20 0.35
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
AR P10275 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17451948 0.84 TOP1 (0.46) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL17403775 0.83 PARP1 (0.46) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL14020765 0.83 PARP1 (0.47) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL11991106 0.82 NPSR1 (0.40) PARP1TOP1MEN1KMT2ANPSR1
SCHEMBL17174105 0.81 PARP1 (0.46) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL17174127 0.81 PARP1 (0.46) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL20108851 0.81 PARP1 (0.44) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL20108871 0.80 TOP1 (0.41) PARP1TOP1MEN1KMT2ARAB9A
SCHEMBL11991067 0.80 TOP1 (0.44) TOP1MEN1KMT2ANPSR1ALDH1A1
SCHEMBL17451977 0.79 TOP1 (0.44) PARP1TOP1PIM1PIM2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2076524-B1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2016-04-20 EP disclosed
EP-2076524-B1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2016-04-20 EP disclosed
US-8735583-B2 Chiral phosphorus compound JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) 2014-05-27 US disclosed
US-8735583-B2 Chiral phosphorus compound JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) 2014-05-27 US disclosed
US-8735583-B2 Chiral phosphorus compound JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) 2014-05-27 US disclosed
US-20130150583-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2013-06-13 US disclosed
US-20130150583-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2013-06-13 US disclosed
US-20130150583-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2013-06-13 US disclosed
US-8404843-B2 Chiral phosphorus compound JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2013-03-26 US disclosed
US-20120264940-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2012-10-18 US disclosed
US-8222415-B2 Chiral phosphorus compound JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2012-07-17 US disclosed
US-20120004411-A9 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2012-01-05 US disclosed
US-20120004411-A9 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2012-01-05 US disclosed
US-20120004411-A9 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2012-01-05 US disclosed
US-20100240898-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2010-09-23 US disclosed
US-20100240898-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2010-09-23 US disclosed
US-20100240898-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2010-09-23 US disclosed
EP-2076524-A1 CHIRAL PHOSPHORUS COMPOUND Johnson Matthey Public Limited Company (GB) 2009-07-08 EP disclosed
WO-2008041029-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2008-04-10 WO disclosed
WO-2008041029-A1 CHIRAL PHOSPHORUS COMPOUND JOHNSON MATTHEY PLC (GB) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264940-A1 CHIRAL PHOSPHORUS COMPOUND PIK3CA, RECQL, P2RY1 PARP1 495/4885TOP1 528/4885MEN1 922/4885
US-20120004411-A9 CHIRAL PHOSPHORUS COMPOUND PIK3CA, RECQL, P2RY1 PARP1 495/4885TOP1 528/4885MEN1 922/4885
US-20100240898-A1 CHIRAL PHOSPHORUS COMPOUND PIK3CA, RECQL, P2RY1 PARP1 495/4885TOP1 528/4885MEN1 922/4885
US-20130150583-A1 CHIRAL PHOSPHORUS COMPOUND ALPP, PTH1R, CALCR PARP1 2019/4885TOP1 1602/4885MEN1 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.